Simon Adamson
Overview
Explore the profile of Simon Adamson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shrestha A, Bashir T, Achison M, Adamson S, Akpan A, Aspray T, et al.
PLoS One
. 2024 Aug;
19(8):e0307268.
PMID: 39093910
Introduction: Understanding genetic contributors to sarcopenia (age-related loss of muscle strength and mass) is key to finding effective therapies. Variants of the bradykinin receptor 2 (BDKRB2) have been linked to...
2.
Bashir T, Achison M, Adamson S, Akpan A, Aspray T, Avenell A, et al.
PLoS One
. 2023 Nov;
18(11):e0294330.
PMID: 37963137
Background: Ageing is associated with changes in body composition including an overall reduction in muscle mass and a proportionate increase in fat mass. Sarcopenia is characterised by losses in both...
3.
Rossios C, Bashir T, Achison M, Adamson S, Akpan A, Aspray T, et al.
PLoS One
. 2023 Oct;
18(10):e0292402.
PMID: 37862321
Background: Angiotensin II (AII), has been suggested to promote muscle loss. Reducing AII synthesis, by inhibiting angiotensin converting enzyme (ACE) activity has been proposed as a method to inhibit muscle...
4.
Crossin R, Cleland L, Wilkins C, Rychert M, Adamson S, Potiki T, et al.
J Psychopharmacol
. 2023 Jun;
37(9):891-903.
PMID: 37353972
Aims: The harms arising from psychoactive drug use are complex, and harm reduction strategies should be informed by a detailed understanding of the extent and nature of that harm. Drug...
5.
Keir H, Long M, Abo-Leyah H, Giam Y, Vadiveloo T, Pembridge T, et al.
Lancet Respir Med
. 2022 Sep;
10(12):1119-1128.
PMID: 36075243
Background: Neutrophil serine proteases are involved in the pathogenesis of COVID-19 and increased serine protease activity has been reported in severe and fatal infection. We investigated whether brensocatib, an inhibitor...
6.
Crossin R, Boden J, Wilkins C, Adamson S
N Z Med J
. 2022 Jun;
135:8-10.
PMID: 35728179
No abstract available.
7.
Achison M, Adamson S, Akpan A, Aspray T, Avenell A, Band M, et al.
J Cachexia Sarcopenia Muscle
. 2022 Feb;
13(2):858-871.
PMID: 35174663
Background: This trial aimed to determine the efficacy of leucine and/or perindopril in improving physical function in older people with sarcopenia. Methods: Placebo-controlled, parallel group, double-blind, randomized two-by-two factorial trial....
8.
Luquiens A, Berger-Viergat A, Larrieu A, Artigaud L, Fener C, Adamson S, et al.
Drug Alcohol Rev
. 2021 Apr;
40(7):1334-1339.
PMID: 33855757
Introduction: Several questionnaires have been developed for screening cannabis use disorder in clinical populations, but very few studies have compared the screening abilities of the different instruments. Here, we aimed...
9.
Adamson S, Kavaliauskas M, Lorimer R, Babraj J
Int J Environ Res Public Health
. 2020 Jan;
17(2).
PMID: 31936725
Exercise is a powerful tool for improving health in older adults, but the minimum frequency required is not known. This study sought to determine the effect of training frequency of...
10.
Sellman D, Adamson S, Foulds J, Beaglehole B, Mulder R
N Z Med J
. 2019 Jul;
132(1498):7-9.
PMID: 31295234
No abstract available.